BIOMARIN PHARMACEUTICAL INC — Director's Dealing 2016

Aug 3, 2016

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BIOMARIN PHARMACEUTICAL INC (BMRN)
CIK: 0001048477
Period of Report: 2016-08-01

Reporting Person: SPIEGELMAN DANIEL K (EVP, Chief Financial Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2016-08-01	Common Stock	S	4000	$99.33	Disposed	42944	Direct

Footnotes

F1: Trade made pursuant to a 10b5-1 plan executed on May 9, 2016.

F2: All shares were sold at the same price.